G Noël, D Antoni - Cancer/radiothérapie, 2022 - Elsevier
Dose constraints are essential for performing dosimetry, especially for intensity modulation and for radiotherapy under stereotaxic conditions. We present the update of the …
GG Hanna, L Murray, R Patel, S Jain, KL Aitken… - Clinical Oncology, 2018 - Elsevier
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the …
Purpose Pancreatic stereotactic body radiation therapy (SBRT) is limited to gross tumor without elective coverage for subclinical disease. Given a better understanding of …
Background Ionizing radiation (IR) is widely used in the treatment of cancer in radiotherapy. One of the main concerns of patients with gastrointestinal cancers undergoing radiotherapy …
C Zhang, Z Liang, S Ma, X Liu - Frontiers in Oncology, 2021 - frontiersin.org
Radiotherapy (RT) shows advantages as one of the most important precise therapy strategies for cancer treatment, especially high-dose hypofractionated RT which is widely …
LA Daamen, SR de Mol van Otterloo… - Acta …, 2022 - Taylor & Francis
Background Introduction of online adaptive MR-guided radiotherapy enables stereotactic body radiation therapy (SBRT) of upper abdominal tumors. This study aimed to evaluate the …
C Greco, O Pares, N Pimentel, V Louro… - International Journal of …, 2019 - Elsevier
Purpose The current oligometastatic (OM) model postulates that the disease evolves dynamically with sequential emergence of OM (SOM) lesions requiring successive rounds of …
L Nicosia, V Figlia, N Ricottone, F Cuccia… - Clinical & Experimental …, 2022 - Springer
Breast cancer is a heterogenous disease with a deep tailoring level. Evidence is accumulating on the role of stereotactic body radiotherapy (SBRT) in the management of …